E2027

Phase 1Completed

0 views this week 0 watching💤 Quiet

Interest: 29/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Dementias With Lewy Bodies

Conditions

Dementias With Lewy Bodies

Trial Timeline

Jul 18, 2019 → Oct 11, 2019

NCT ID

NCT04023877

About E2027

E2027 is a phase 1 stage product being developed by Eisai for Dementias With Lewy Bodies. The current trial status is completed. This product is registered under clinical trial identifier NCT04023877. Target conditions include Dementias With Lewy Bodies.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (2)

NCT ID	Phase	Status	Start	Completion	Indication
NCT04764669	Phase 2	Completed	Feb 25, 2021	Jan 27, 2022	Lewy Body Disease
NCT04023877	Phase 1	Completed	Jul 18, 2019	Oct 11, 2019	Dementias With Lewy Bodies